Episode 13: Alberto Conde Mellado, Founder of Glucovibes

Glucovibes Founder Alberto Conde Mellado reveals how combining continuous glucose monitoring with AI is transforming chronic disease management. Learn why the future of healthcare lies in turning personal data into actionable lifestyle insights.

In this episode, you'll hear about:

• Health innovation: revolutionizing diabetes care through real-time monitoring and analytics
• Data transformation: converting glucose readings into personalized lifestyle recommendations
• Investment insights: identifying breakthrough opportunities in digital health
• Scale strategy: growing from startup to leading European health tech player
• Future vision: shaping the next generation of chronic disease management

Essential for HealthTech founders and digital health innovators building the future of personalized medicine. Discover how merging continuous monitoring with smart analytics is creating new standards in chronic disease care. Check it out!

Our guest today is Alberto Conde Mellado, Founder of Glucovibes

In episode 13, we're excited to feature Alberto Conde Mellado, a trailblazer in the European digital and health tech spheres. As the CEO and Co-founder of Inmotion Ventures, Alberto has strategically grown the firm into a leading venture capital investor focused on early-stage mobility and transportation startups across Europe.

However, Alberto's most recent and impactful venture is Glucovibes, the digital health company he co-founded to revolutionize diabetes management. Leveraging his deep experience in technology and entrepreneurship, Alberto led the development of Glucovibes' innovative platform that seamlessly integrates continuous glucose monitoring, personalized analytics, and lifestyle coaching.

With over 15 years of experience in the tech industry, Alberto has honed his ability to identify disruptive innovations and nurture the growth of groundbreaking companies.

Alberto's unique blend of entrepreneurial spirit, investment acumen, and passionate commitment to improving healthcare outcomes have positioned him as a prominent voice shaping the future of digital health in Europe. We look forward to delving into his insights and vision for the evolving landscape of chronic disease management.